CivicaScript® Lowers Prices for Better Access
Reducing costs leads to improved accessibility for patients and pharmacies.
CivicaScript, a dedicated nonprofit organization focused on providing affordable generic medications in the U.S., has recently announced a significant reduction in the price of its leading product, Abiraterone Acetate Tablets, USP 250 mg. This decision aligns with the organization's mission to ensure that essential medications remain accessible to all consumers.
Price Reduction Details
The new price for Abiraterone Acetate Tablets will be available to pharmacies at $120 per bottle, representing a 25 percent decrease from the previous price of $160 per bottle. CivicaScript has also advised pharmacies that they should not charge patients more than $141 per bottle, reflecting a nearly 18 percent discount. This bottle typically contains 120 tablets, providing a month's supply for patients.
Context of Price Reduction
This price reduction emerges amidst a broader context where several pharmaceutical companies are announcing price hikes for numerous medications in the current year. A recent report by the Federal Trade Commission highlighted that major U.S. pharmacy benefit managers (PBMs) have been inflating generic abiraterone prices by astonishing amounts, leading to increased costs for both patients and health plans.
Commitment to Patients Over Profits
CivicaScript's philosophy emphasizes the importance of prioritizing patient welfare over profit margins. According to the organization's President, Brent J. Eberle, they have achieved favorable volume discounts for the abiraterone product, passing these savings directly onto their patient members. This recent price adjustment demonstrates the effectiveness of their patient-centered business model.
Future Product Launches
Looking ahead, CivicaScript plans to launch additional products throughout the year, continuously aiming to address the challenges posed by high medication prices in the market.
Understanding Abiraterone's Role
Abiraterone is utilized in conjunction with steroid medications such as prednisone, serving as a treatment for prostate cancer that has metastasized to other organs. The recently adjusted maximum retail pricing ensures that patients with Medicare Part D insurance stand to save considerable amounts—approximately $2,900 less each month compared to average expenditures for the same medication.
Addressing Generic Medication Challenges
Despite the fact that generics are usually more cost-effective than their brand-name counterparts, certain high-cost generics remain excessively pricey due to substantial markups imposed by PBMs and a lack of market competition. Numerous studies underscore the impact of medication pricing on patient behavior, influencing their ability to obtain prescribed treatments.
CivicaScript's Operations and Values
CivicaScript actively identifies high-priced generic medications and collaborates with manufacturers to deliver them to market at significantly lower costs. By partnering with like-minded PBMs, pharmacies, and payors, the organization works diligently to transfer these savings to their customers.
About CivicaScript
CivicaScript operates under Civica, Inc. and is dedicated to fostering transparency throughout the drug supply chain, ensuring that high-quality generic medications are both affordable and accessible. By adhering to the principles of social welfare and community health, CivicaScript serves more than 100 million lives across the United States.
Frequently Asked Questions
What is CivicaScript?
CivicaScript is a nonprofit organization focused on providing affordable and transparent access to generic medications in the U.S.
What medications does CivicaScript offer?
CivicaScript offers various generic medications, including Abiraterone Acetate Tablets, designed to be more affordable for patients.
How does CivicaScript ensure low prices?
By negotiating volume discounts and collaborating with pharmaceutical partners, CivicaScript can sell medications at reduced prices.
Who benefits from CivicaScript's price reductions?
The price reductions benefit pharmacies, patients, and health plans by making essential medications more affordable and accessible.
Are there future products planned by CivicaScript?
Yes, CivicaScript has plans to launch more products in the upcoming year to further enhance access to essential medications.
